Bal Pharma Commences Commercial Production At Its New API Manufacturing Unit In Rajasthan
Bal Pharma Limited informs that after obtaining all the regulatory approvals, the bulk drugs manufacturing unit at Udaipur has commenced its commercial production of intermediates and Active Pharma Ingredients (APl).
The API products which of scheduled to be manufactured at this Unit were developed by our R&D facility at Bangalore and due to capacity constraints at our Bangalore facility they could not become commercially viable till now.
This unit is expected to ease the capacity concerns of APl's and intermediates and will cater to the North are Northeastern markets of the country and also overseas markets.
To recapitulate, the company have acquired 100% shareholding and management control of Golden Drugs Private Limited, Udaipur, Rajasthan, which is into manufacturing of APl's and intermediates, during March 2018.